Akahoshi Takayuki
Cataract and Refractive Surgery Department, Nihonbashi Cataract Clinic, Tokyo, Japan.
Clin Ophthalmol. 2024 Jul 11;18:2021-2031. doi: 10.2147/OPTH.S471846. eCollection 2024.
To analyze the refractive and visual outcomes following cataract surgery and implantation of a new hydrophobic trifocal toric intraocular lens (IOL) in Japanese eyes with different degrees of corneal astigmatism.
A total of 66 eyes from 39 patients implanted with a FineVision HP Toric IOL (Beaver-Visitec International Inc) were analyzed retrospectively. The main outcome measures considered were refraction, monocular uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), uncorrected intermediate visual acuity (UIVA), and distance-corrected intermediate visual acuity (DCIVA) at 80 and 66 cm, uncorrected near visual acuity (UNVA) and distance-corrected near visual acuity (DCNVA) at 40 cm. Eyes were evaluated at three months post-surgery.
Sixty-five eyes (98.48%) were within ±0.50D of spherical equivalent, and all were within ±1.00D (mean: 0.00±0.21D). Moreover, 63 eyes (95.45%) had ≤0.50D of residual astigmatism, and all had ≤1.00D (mean: -0.08±0.23D). Similarly, 58 (87.88%) and 60 eyes (90.91%) had ≥20/20 UDVA and CDVA, respectively, with 65 (98.48%) and 66 eyes (100%) achieving ≥20/25 UDVA and CDVA, respectively. In addition, 28 (42.42%) and 23 eyes (34.85%) had ≥20/25 DCIVA at 80 and 66 cm, respectively, with 49 (74.24%) and 52 eyes (78.79%) achieving ≥20/32 DCIVA at 80 and 66 cm, respectively. Finally, 39 (59.09%) and 40 eyes (60.61%) had ≥20/20 UNVA and DCNVA, respectively, with 58 (87.88%) and 59 eyes (89.39%) achieving ≥20/25 UNVA and DCNVA, respectively.
Our study shows that implantation of the new hydrophobic FineVision HP Toric IOL results in accurate refractive outcomes, with good visual acuity at different distances, in Japanese eyes.
分析在不同程度角膜散光的日本患者眼中，白内障手术后植入新型疏水三焦点散光人工晶状体（IOL）后的屈光和视觉效果。
回顾性分析了39例患者的66只眼，这些眼睛植入了FineVision HP Toric IOL（Beaver-Visitec International Inc）。主要观察指标包括术后三个月时的屈光、单眼未矫正远视力（UDVA）、矫正远视力（CDVA）、未矫正中视力（UIVA）、80和66厘米处的距离矫正中视力（DCIVA）、40厘米处的未矫正近视力（UNVA）和距离矫正近视力（DCNVA）。
65只眼（98.48%）的等效球镜度在±0.50D以内，所有眼睛均在±1.00D以内（平均：0.00±0.21D）。此外，63只眼（95.45%）的残余散光≤0.50D，所有眼睛均≤1.00D（平均：-0.08±0.23D）。同样，分别有58只眼（87.88%）和60只眼（90.91%）的UDVA和CDVA≥20/20，分别有65只眼（98.48%）和66只眼（100%）的UDVA和CDVA≥20/25。此外，分别有28只眼（42.42%）和23只眼（34.85%）在80和66厘米处的DCIVA≥20/25，分别有49只眼（74.24%）和52只眼（78.79%）在80和66厘米处的DCIVA≥20/32。最后，分别有39只眼（59.09%）和40只眼（60.61%）的UNVA和DCNVA≥20/20，分别有58只眼（87.88%）和59只眼（89.39%）的UNVA和DCNVA≥20/25。
我们的研究表明，在日本患者眼中植入新型疏水FineVision HP Toric IOL可获得准确的屈光效果，在不同距离下均有良好的视力。
